Federal Kratom Consumer Protection Act

The Federal Kratom Consumer Protection Act (S 3039) requires the FDA to hold public hearings on kratom safety and research, establish a 2-year Kratom Research Task Force to coordinate federal studies, and prevent the FDA from imposing stricter regulations on kratom products than those for food or dietary supplements. The bill mandates quarterly reports on kratom research, public meetings, and transparency through FDA website updates, while prohibiting the FDA from treating kratom as an adulterated supplement or requiring new dietary ingredient notifications. It directly affects kratom manufacturers, sellers, and consumers by maintaining current regulatory status for kratom products under the Federal Food, Drug, and Cosmetic Act. The law also prevents FDA import alerts without evidence of product adulteration and explicitly states it does not override state laws governing kratom.